Twenty-one days of hydrogen sulfide supplementation restored blood perfusion and muscle function in diabetic mice with induced limb ischemia while simultaneously rebalancing their gut microbiome. The treatment increased beneficial bacteria including Lactobacillus murinus and Faecalibacterium prausnitzii while reducing inflammatory species like Ruminococcus sp. JE7A12. Critically, H2S normalized the elevated Firmicutes-to-Bacteroidetes ratio, a marker associated with metabolic dysfunction. This dual therapeutic effect connects two seemingly disparate biological systems through H2S signaling. The gut-vascular axis represents an emerging frontier in understanding how microbial communities influence cardiovascular health, particularly in diabetes where both systems are compromised. While the 21-day timeframe and mouse model limit immediate clinical translation, the findings suggest H2S could address multiple pathological processes simultaneously. The identification of 28 differentially expressed microbial genes, particularly those in carbohydrate metabolism pathways, hints at mechanistic connections between gut function and peripheral circulation. This represents more than symptom management—it suggests H2S may restore fundamental metabolic communication networks. However, the complexity of translating precise microbial changes from mice to humans remains substantial.